BRIEF RESEARCH REPORT
Published on 07 Jan 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
doi 10.3389/fimmu.2025.1514033
284
Total views and downloads
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
You will be redirected to our submission process.